<SEC-DOCUMENT>0001193125-26-187691-index.html : 20260428
<SEC-HEADER>0001193125-26-187691.hdr.sgml : 20260428
<ACCEPTANCE-DATETIME>20260428170703
ACCESSION NUMBER:		0001193125-26-187691
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260428
DATE AS OF CHANGE:		20260428
EFFECTIVENESS DATE:		20260428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Xilio Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001840233
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				851623397
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40925
		FILM NUMBER:		26909104

	BUSINESS ADDRESS:	
		STREET 1:		828 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		617-833-1027

	MAIL ADDRESS:	
		STREET 1:		828 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>2026_04_28_-_ars.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: 2026_04_28_-_ars.pdf

</DOCUMENT>
</SEC-DOCUMENT>